Simplex Trading’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,200
| Closed | -$37.9K | – | 10287 |
|
|
2025
Q4 | $37.9K | Buy |
4,200
+200
| +5% | +$1.5K | ﹤0.01% | 5903 |
|
|
2025
Q3 | $12K | Buy |
4,000
+1,500
| +60% | +$3.97K | ﹤0.01% | 7783 |
|
|
2025
Q2 | $5K | Sell |
2,500
-1,900
| -43% | -$3.07K | ﹤0.01% | 7786 |
|
|
2025
Q1 | $5K | Sell |
4,400
-10,100
| -70% | -$17.3K | ﹤0.01% | 7613 |
|
|
2024
Q4 | $31K | Sell |
14,500
-6,400
| -31% | -$14.5K | ﹤0.01% | 6335 |
|
|
2024
Q3 | $45K | Sell |
20,900
-56,800
| -73% | -$131K | ﹤0.01% | 5990 |
|
|
2024
Q2 | $179K | Buy |
77,700
+69,000
| +793% | +$287K | ﹤0.01% | 4765 |
|
|
2024
Q1 | $47K | Sell |
8,700
-31,700
| -78% | -$145K | ﹤0.01% | 6318 |
|
|
2023
Q4 | $99K | Buy |
40,400
+38,500
| +2,026% | +$366K | ﹤0.01% | 5404 |
|
|
2023
Q3 | $65K | Buy |
1,900
+1,700
| +850% | +$58.8K | ﹤0.01% | 5557 |
|
|
2023
Q2 | $6K | Sell |
200
-1,200
| -86% | -$41.4K | ﹤0.01% | 7851 |
|
|
2023
Q1 | $46K | Sell |
1,400
-100
| -7% | -$3.89K | ﹤0.01% | 6021 |
|
|
2022
Q4 | $49K | Sell |
1,500
-4,100
| -73% | -$121K | ﹤0.01% | 5930 |
|
|
2022
Q3 | $195K | Buy |
+5,600
| New | +$124K | ﹤0.01% | 4647 |
|
Other funds holding VTYX
Simplex Trading's VTYX Position: Q4 2025 in Review
Simplex Trading sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 49,959 shares — an estimated $373K sold.
Simplex Trading first reported a position in VTYX in Q4 2023 and held it in 7 quarters. The position peaked at $327K in Q4 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.
- Simplex Trading reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 49,959 Ventyx Biosciences shares in Q4 2025, an estimated $373K.
- Simplex Trading first reported a position in Ventyx Biosciences in Q4 2023 and held it in 7 quarters.
- Simplex Trading's Ventyx Biosciences position peaked at $327K in Q4 2024.
- 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.